Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/12/26 | 424B3 | Prospectus [Rule 424(b)(3)] |
|
40 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/11/26 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
  |
39 |
